Abstract
To study and evaluate the effect of selenium and its relationship with prostate tumors, one hundred samples were taken for the study, including 60 patients with prostate cancer and 40 healthy subjects from Iraqi men. The levels of the serum selenium were measured in the samples of infected men with prostate tumor and healthy subjects, after the samples were drawn from the study cases. Flameless Atomic Absorption used for measuring. The data were statistically analyzed by SPSS. Also prostate specific antegene (PSA) was measured as an indicator of prostate tumor. The results showed that there was a significant difference between patients with prostate tumor and selenium trace element, which was observed in malignantprostatecancer patients (4.27 ± 0.93), benign prostate cancer patients (6.12 ± 0.54) and healthy (9.30 ± 1.72)) When comparing study groups, according to the severity of prostate disease in men The study recommends to provide adequate support and guidance for them and give selenium to men after the age of 45 years.
First Page
13
Last Page
21
Recommended Citation
Salam, Hussein; Mohameed, Abdulameer Jasim; and Abdulameer, Zena
(2019)
"The role of Selenium Trace Element in Iraqi Patients with Prostate Tumors,"
Al-Nisour Journal for Medical Sciences: Vol. 1:
Iss.
1, Article 2.
DOI: https://doi.org/10.70492/2664-0554.1012